Complete Blood Count (CBC), Coagulation Panel (PT/INR, aPTT, Fibrinogen, D-Dimer), Liver Panel & Cardiac Biomarkers (Troponin, BNP, Lactate)
NCLEX reference ranges and clinical interpretation for Complete Blood Count (RBC, Hgb/Hct, MCV anemia classification, iron/B12/folate studies, WBC differential, ANC/neutropenic precautions, platelets), coagulation panel (PT/INR, aPTT, fibrinogen, D-dimer, DIC), liver/pancreatic enzymes, cardiac biomarkers (troponin, BNP/NT-proBNP, lactate), HbA1c, and thyroid/lipid panels.
- Level
- basic
- Languages
- en → en
- Cards
- 32
- Markdown
- Complete Blood Count (CBC), Coagulation Panel (PT/INR, aPTT, Fibrinogen, D-Dimer), Liver Panel & Cardiac Biomarkers (Troponin, BNP, Lactate) (.md)
Flashcards (32)
| # | Front (Term / Question) | Back (Definition / Answer) | Example | Multiple-Choice Options |
|---|---|---|---|---|
| 1 | What are the optimal adult Fasting Lipid Panel targets (Total Cholesterol, LDL-C, HDL-C, Triglycerides), and above what Triglyceride threshold is there a high risk of Acute Pancreatitis? | Desirable Total Cholesterol: < 200 mg/dL; LDL-C ('bad' atherogenic cholesterol): < 100 mg/dL (< 70 mg/dL or < 55 mg/dL in clinical ASCVD); HDL-C ('good' reverse-transport cholesterol): > 40 mg/dL in men, > 50 mg/dL in women (>= 60 mg/dL is cardioprotective); Triglycerides: < 150 mg/dL; Severe hypertriglyceridemia >= 500–1,000 mg/dL carries a high risk of acute pancreatitis (treated with fibrates, omega-3 fatty acids, or IV insulin infusion). | ||
| 2 | What are the normal reference ranges for Prothrombin Time (PT), International Normalized Ratio (INR), and Activated Partial Thromboplastin Time (aPTT)? | PT: 11–13.5 seconds; Baseline INR (not on anticoagulation): 0.8–1.1 (therapeutic Warfarin INR: 2.0–3.0 for AFib/DVT/PE, or 2.5–3.5 for mechanical mitral valve; reversed in life-threatening bleeding with 4-factor PCC [Kcentra] + IV Vitamin K); Baseline aPTT: 25–35 seconds (therapeutic unfractionated heparin aPTT is typically 1.5–2.5 times baseline, or ~60–80 seconds, correlated with anti-Xa 0.3–0.7 IU/mL; reversed with IV Protamine Sulfate). | ||
| 3 | Why must serial Cardiac Troponins be drawn (e.g., at 0 hours and 2–6 hours), and what non-ACS conditions can cause an elevated Troponin without acute plaque rupture? | A single early troponin drawn within 1–2 hours of chest pain onset may be falsely negative before myocyte necrosis releases cytosolic/structural troponin; non-ACS elevations (Type 2 MI / myocardial injury) occur in severe renal failure (impaired clearance), acute pulmonary embolism (RV strain), decompensated heart failure, myocarditis/pericarditis, sepsis, tachyarrhythmias, and stroke. | ||
| 4 | What are the normal reference range for Thyroid-Stimulating Hormone (TSH, 0.4–4.5 mIU/L) and Free T4 (0.8–1.8 ng/dL), and how do they distinguish Primary versus Central Hypothyroidism and Hyperthyroidism? | Primary Hypothyroidism (Hashimoto thyroiditis): HIGH TSH, LOW Free T4 (Subclinical hypothyroidism: High TSH, Normal Free T4); Central (Secondary/Pituitary) Hypothyroidism: LOW or inappropriately normal TSH, LOW Free T4; Primary Hyperthyroidism (Graves disease, toxic nodule): SUPPRESSED/LOW TSH (< 0.05), HIGH Free T4 and/or Free T3; Secondary Hyperthyroidism (TSH-secreting pituitary adenoma): High/unsuppressed TSH, High Free T4. | ||
| 5 | How does an Iron Panel (Serum Iron, Ferritin, Total Iron-Binding Capacity [TIBC], Transferrin Saturation, RDW) distinguish Iron Deficiency Anemia from Anemia of Chronic Disease? | Iron Deficiency Anemia: Low serum ferritin (< 15–30 ng/mL, most sensitive/specific test), low serum iron, HIGH TIBC/transferrin, low transferrin saturation (< 15%), and elevated RDW; Anemia of Chronic Disease (hepcidin blocks ferroportin iron release from macrophages): HIGH or normal serum ferritin (> 100 ng/mL, acute-phase reactant), low serum iron, LOW TIBC, and low-to-normal transferrin saturation. | ||
| 6 | What is the normal Platelet Count, and at what platelet thresholds do spontaneous mucocutaneous bleeding, surgical bleeding, and intracranial hemorrhage risks occur? | Normal Platelets: 150,000–400,000/mm³ (150–400 × 10⁹/L); Thrombocytopenia is < 150,000/mm³; < 50,000/mm³ increases risk of bleeding with minor trauma or invasive procedures (transfuse platelets prior to major surgery); < 20,000/mm³ causes spontaneous petechiae, purpura, epistaxis, and gingival bleeding; < 10,000/mm³ carries high risk of spontaneous fatal intracranial hemorrhage (indication for prophylactic platelet transfusion in non-bleeding patients). | ||
| 7 | How is Hepatic Encephalopathy triggered in cirrhosis, and how does Oral Lactulose (+ Rifaximin) work to lower blood ammonia? | Triggered by GI bleeding (high nitrogen load), constipation, infection/SBP, hypokalemia/alkalosis (converts NH4+ to diffusible NH3 across the blood-brain barrier), dehydration/diuretics, or TIPS placement; colonic bacteria cleave Lactulose into lactic/acetic acids, acidifying the colonic lumen to trap diffusible Ammonia (NH3) as non-absorbable Ammonium ions (NH4+) and promoting cathartic excretion (titrated to 2–3 soft stools/day), while Rifaximin eradicates ammonia-producing gut flora. | ||
| 8 | How do you distinguish Unconjugated (Indirect) Hyperbilirubinemia from Conjugated (Direct) Hyperbilirubinemia, and which type appears in urine? | Unconjugated (Indirect) bilirubin is water-INSOLUBLE and tightly bound to albumin (cannot be filtered by the glomerulus -> ABSENT in urine), elevated in hemolysis, Gilbert syndrome (mildly decreased UGT1A1 activity during fasting/stress), and Crigler-Najjar syndrome; Conjugated (Direct) bilirubin is water-SOLUBLE (excreted in urine causing dark 'tea-colored' bilirubinuria), elevated in biliary obstruction (gallstones, pancreatic cancer), hepatitis/cirrhosis, and Dubin-Johnson/Rotor syndromes. | ||
| 9 | How do Platelets, Bleeding Time, PT, and aPTT behave in Von Willebrand Disease (vWD) versus Hemophilia A or B? | Von Willebrand Disease (most common inherited bleeding disorder, autosomal dominant deficiency of vWF, which bridges platelets to subendothelial collagen via GpIb and protects Factor VIII from degradation): normal platelet count, prolonged Bleeding Time/PFA-100, normal PT, and normal or mildly prolonged aPTT (treated with desmopressin [DDAVP] or vWF concentrate); Hemophilia A (Factor VIII) or B (Factor IX, X-linked recessive): normal platelet count, normal PT, and isolated PROLONGED aPTT (hemarthroses and deep muscle hematomas). | ||
| 10 | What are the normal reference ranges and rising/peaking/clearing kinetics of Cardiac Troponin I / T (cTnI/cTnT) versus CK-MB in Acute Myocardial Infarction? | Standard Cardiac Troponin I (< 0.04 ng/mL; high-sensitivity hs-cTnT < 14 ng/L in females, < 22 ng/L in males) is the gold-standard biomarker with highest sensitivity and myocardial specificity: rises within 2–4 hours of symptom onset, peaks at 12–24 hours, and remains elevated for 7–14 days; CK-MB (< 5 ng/mL or < 3–5% of total CK) rises within 4–6 hours, peaks at 18–24 hours, and returns to baseline within 48–72 hours (historically useful for detecting early reinfarction). | ||
| 11 | What are the reference ranges and clinical targets for Fasting Plasma Glucose, 2-Hour Oral Glucose Tolerance Test, and Hemoglobin A1c (HbA1c)? | Normal: Fasting Glucose 70–99 mg/dL, 2-hr OGTT < 140 mg/dL, HbA1c < 5.7%; Prediabetes: Fasting Glucose 100–125 mg/dL, 2-hr OGTT 140–199 mg/dL, HbA1c 5.7%–6.4%; Diabetes Mellitus: Fasting Glucose >= 126 mg/dL, 2-hr OGTT >= 200 mg/dL, HbA1c >= 6.5%, or random glucose >= 200 mg/dL with classic symptoms (Target HbA1c for most non-pregnant adults with diabetes is < 7.0%; inpatient hospitalized glycemic target is 140–180 mg/dL). | ||
| 12 | Where are B-Type Natriuretic Peptide (BNP) and NT-proBNP synthesized, what triggers their release, and how are their serum levels interpreted in acute dyspnea? | Synthesized by ventricular cardiomyocytes as pre-proBNP and cleaved into active BNP and inactive NT-proBNP in response to ventricular wall stretch and volume/pressure overload; BNP < 100 pg/mL (or NT-proBNP < 300 pg/mL) has a ~90–98% negative predictive value to RULE OUT acute decompensated heart failure as the cause of dyspnea (pointing toward COPD/pneumonia), whereas BNP > 400 pg/mL strongly supports heart failure (Note: obesity falsely lowers BNP, while CKD/older age raises baseline BNP/NT-proBNP). | ||
| 13 | How do you determine whether an isolated elevation of Alkaline Phosphatase (ALP) originates from the Hepatobiliary Tree versus Bone? | Measure Gamma-Glutamyl Transferase (GGT) or 5'-nucleotidase: if GGT is simultaneously elevated (often with conjugated hyperbilirubinemia), the ALP elevation is hepatobiliary/cholestatic in origin (biliary obstruction, primary biliary cholangitis, primary sclerosing cholangitis); if GGT and bilirubin are normal, the ALP elevation originates from high bone turnover (Paget disease of bone, osteomalacia, bone metastases, adolescent growth spurt, or third-trimester placenta). | ||
| 14 | What is the normal Reticulocyte Count (0.5%–2.0%), and what does a low (< 2%) versus high (> 2–3%) Corrected Reticulocyte Production Index indicate in anemia? | Reticulocytes are immature RBCs released from bone marrow over the preceding 24–48 hours; a LOW reticulocyte index (< 2%) indicates hypoproliferative bone marrow failure or nutritional deficiency (iron, B12, folate, aplastic anemia, CKD), whereas a HIGH reticulocyte index (> 2–3%) indicates an appropriate vigorous marrow response to acute hemorrhage or peripheral hemolysis. | ||
| 15 | How do Serum Homocysteine and Methylmalonic Acid (MMA) levels distinguish Vitamin B12 (Cobalamin) deficiency from Folate (Vitamin B9) deficiency in megaloblastic anemia? | Both Vitamin B12 and Folate deficiencies elevate Serum Homocysteine (because both are required for methionine synthase); however, ONLY Vitamin B12 deficiency elevates Methylmalonic Acid (MMA), because B12 is the exclusive cofactor for methylmalonyl-CoA mutase (accumulated MMA causes myelin damage and subacute combined degeneration). | ||
| 16 | How does Sacubitril/Valsartan (an ARNI) affect measured BNP versus NT-proBNP levels in Heart Failure with Reduced Ejection Fraction (HFrEF)? | Sacubitril inhibits Neprilysin, the enzyme that degrades biologically active BNP, thereby Pharmacologically INCREASING serum BNP levels; because neprilysin does NOT degrade NT-proBNP, clinicians must monitor NT-proBNP (which decreases as heart failure improves) rather than BNP in patients taking sacubitril/valsartan. | ||
| 17 | What are the normal reference ranges for Plasma Fibrinogen and D-Dimer, and how is Disseminated Intravascular Coagulation (DIC) distinguished from Severe Liver Disease? | Normal Fibrinogen: 200–400 mg/dL; Normal D-Dimer: < 500 ng/mL (< 0.5 mcg/mL FEU); in DIC (consumptive coagulopathy triggered by sepsis, trauma, obstetrics, or AML-M3), platelets and fibrinogen (< 100 mg/dL) are markedly LOW, PT/aPTT and D-Dimer are markedly HIGH, smear shows schistocytes, and Factor VIII is LOW; in severe liver disease, PT/INR is high and platelets/fibrinogen may be low, but Factor VIII (synthesized by vascular endothelial cells, NOT hepatocytes) is NORMAL or ELEVATED. | ||
| 18 | What are the normal reference ranges for the Hepatocellular and Cholestatic Liver Panel (AST, ALT, Alkaline Phosphatase, GGT, Total and Direct Bilirubin, Albumin, Ammonia)? | AST (aspartate aminotransferase): 10–40 U/L; ALT (alanine aminotransferase, more specific to liver cytosol): 7–56 U/L; Alkaline Phosphatase (ALP): 40–120 U/L; GGT: 9–48 U/L; Total Bilirubin: 0.1–1.2 mg/dL; Direct (conjugated) Bilirubin: 0.0–0.3 mg/dL; Serum Albumin: 3.5–5.0 g/dL; Plasma Ammonia (NH3): 15–45 mcg/dL. | ||
| 19 | Why does Hemoglobin A1c reflect a 2-to-3-month average of blood glucose, and what conditions falsely lower or falsely elevate HbA1c? | Glucose non-enzymatically glycates hemoglobin continuously across the ~120-day lifespan of red blood cells; conditions that SHORTEN RBC lifespan (hemolytic anemia, sickle cell disease, G6PD deficiency, acute blood loss, recent transfusion, EPO therapy) FALSELY LOWER HbA1c, whereas conditions that decrease RBC turnover (iron, B12, or folate deficiency anemia, splenectomy, uremia) FALSELY ELEVATE HbA1c. | ||
| 20 | In which clinical conditions is Platelet Transfusion CONTRAINDICATED or avoided despite severe thrombocytopenia unless life-threatening hemorrhage is present? | Heparin-Induced Thrombocytopenia (HIT) and Thrombotic Thrombocytopenic Purpura (TTP) / Hemolytic Uremic Syndrome (HUS), because transfused platelets 'fuel the fire' and precipitate catastrophic arterial and venous thrombosis (also relative inefficiency in Immune Thrombocytopenia [ITP], where autoantibodies rapidly destroy transfused platelets). | ||
| 21 | What are the diagnostic criteria for Acute Pancreatitis, and why is Serum Lipase preferred over Serum Amylase? | Diagnosis requires at least 2 of 3 criteria: 1) characteristic acute epigastric pain radiating to the back, 2) Serum Lipase (or Amylase) >= 3 times the upper limit of normal (normal Lipase: 10–140 U/L; Amylase: 30–110 U/L), and/or 3) characteristic CT/MRI/ultrasound findings; Serum Lipase is preferred because it is more specific to the pancreas (amylase also rises in parotitis, bowel perforation, renal failure, and macroamylasemia) and remains elevated longer (8–14 days vs. 3–5 days for amylase). | ||
| 22 | What are the normal adult reference ranges for Red Blood Cell (RBC) count, Hemoglobin (Hgb), and Hematocrit (Hct) in males versus females? | Males: RBC 4.5–5.9 million/mm³, Hemoglobin 13.5–17.5 g/dL, Hematocrit 41–50%; Females: RBC 4.0–5.2 million/mm³, Hemoglobin 12.0–16.0 g/dL, Hematocrit 36–46% (Note: Hematocrit is roughly 3 times the Hemoglobin value). | ||
| 23 | What is the clinical utility of a Plasma D-Dimer assay in suspected Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE)? | D-Dimer (a fibrin degradation product formed when plasmin cleaves cross-linked fibrin) has high SENSITIVITY (> 95%) and Negative Predictive Value but poor specificity (elevated in surgery, pregnancy, cancer, infection, age); therefore, a NEGATIVE D-Dimer (< 500 ng/mL) safely rules out DVT/PE in patients with LOW or intermediate pre-test probability (Wells score), whereas a positive D-Dimer requires definitive imaging (compression ultrasound or CT pulmonary angiography). | ||
| 24 | How do you calculate the Absolute Neutrophil Count (ANC), what defines Severe Neutropenia, and what are standard Neutropenic Precautions? | ANC = Total WBC (cells/mm³) × [(% Segmented Neutrophils + % Bands) / 100]; Neutropenia is ANC < 1,500/mm³, and Severe (profound) Neutropenia is ANC < 500/mm³ (where Febrile Neutropenia is a single oral temp >= 38.3°C [101°F] or >= 38.0°C [100.4°F] for 1 hr, requiring immediate blood cultures and empiric anti-pseudomonal IV beta-lactam within 60 min); precautions include private room, strict hand hygiene, avoiding rectal temperatures/suppositories/enemas, and avoiding fresh flowers/standing water/unwashed raw produce. | ||
| 25 | What laboratory panel findings confirm Intravascular or Extravascular Hemolytic Anemia? | Elevated indirect (unconjugated) bilirubin, elevated Lactate Dehydrogenase (LDH, released from lysed RBCs), DECREASED serum Haptoglobin (which binds free hemoglobin and is cleared by the liver), reticulocytosis, and characteristic peripheral blood smear findings (schistocytes in MAHA/DIC/TTP; spherocytes with positive Coombs test in autoimmune hemolytic anemia). | ||
| 26 | Which coagulation pathways and clotting factors are measured by the PT/INR versus the aPTT? | PT/INR measures the Extrinsic and Common pathways (Factors VII, X, V, II [prothrombin], and I [fibrinogen] — sensitive to Warfarin and early Vitamin K deficiency or liver failure because Factor VII has the shortest half-life of ~4–6 hours); aPTT measures the Intrinsic and Common pathways (Factors XII, XI, IX, VIII, X, V, II, and I — sensitive to Unfractionated Heparin and Hemophilia A [Factor VIII] or B [Factor IX]). | ||
| 27 | What is the normal reference range for Mean Corpuscular Volume (MCV), and what are the differential diagnoses for Microcytic (< 80 fL), Normocytic (80–100 fL), and Macrocytic (> 100 fL) anemias? | Normal MCV: 80–100 fL. Microcytic (< 80 fL, 'TAILS'): Thalassemia, Anemia of chronic disease (late), Iron deficiency, Lead poisoning, Sideroblastic anemia; Normocytic (80–100 fL): acute blood loss, early anemia of chronic disease, CKD (low EPO), aplastic anemia, hemolysis (sickle cell, G6PD, hereditary spherocytosis); Macrocytic (> 100 fL): Megaloblastic (Vitamin B12 or Folate deficiency with hypersegmented neutrophils) vs. Non-megaloblastic (alcoholism, liver disease, hypothyroidism, reticulocytosis). | ||
| 28 | How does the pattern of AST and ALT elevation distinguish Alcoholic Hepatitis, Acute Viral/Toxin Hepatitis, and Non-Alcoholic Steatohepatitis (MASLD/NASH)? | Alcoholic hepatitis classically shows an AST:ALT ratio >= 2:1 with total transaminases rarely exceeding 300–500 U/L (because alcohol depletes pyridoxal-5'-phosphate [Vitamin B6], which is required more for ALT synthesis than mitochondrial AST) plus elevated GGT; Acute Viral Hepatitis (A–E), Acetaminophen toxicity, or Ischemic Hepatitis ('shock liver') shows massive transaminase elevations (> 1,000–10,000 U/L) with ALT > AST; MASLD/NASH shows mild elevations (< 300 U/L) with ALT > AST. | ||
| 29 | What is the normal total White Blood Cell (WBC) count, and what are the five leukocyte types in order of normal abundance ('Never Let Monkeys Eat Bananas')? | Total WBC count: 4,500–11,000 cells/mm³ (4.5–11.0 × 10⁹/L); 1) Neutrophils (segs + bands): 50–70%; 2) Lymphocytes: 20–40%; 3) Monocytes: 2–8%; 4) Eosinophils: 1–4%; 5) Basophils: 0.5–1%. | ||
| 30 | What is a 'Left Shift' (bandemia) on a WBC differential, and what clinical conditions elevate Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils? | 'Left shift' = > 6–10% immature band neutrophils released from marrow during acute bacterial infection/sepsis; Neutrophilia: bacterial infection, acute stress, corticosteroids (demargination); Lymphocytosis: viral infections (EBV, CMV, hepatitis), Bordetella pertussis, CLL; Monocytosis: chronic intracellular infections (TB, brucellosis), recovery from neutropenia; Eosinophilia ('NAACP'): Neoplasia, Asthma/Allergy, Addison disease, Collagen vascular (EGPA), Parasites (helminths); Basophilia: Chronic Myeloid Leukemia (CML) and myeloproliferative neoplasms. | ||
| 31 | Which laboratory tests best reflect true Hepatic Synthetic Function (acute vs. chronic) rather than hepatocellular injury/leakage? | Prothrombin Time / INR (reflects acute hepatic synthesis of clotting factors II, VII, IX, X within 24 hours due to Factor VII's short half-life; does NOT correct with Vitamin K in severe hepatocellular failure) and Serum Albumin (reflects chronic hepatic protein synthesis, given albumin's long half-life of ~20 days). | ||
| 32 | What are the normal and critical thresholds for Serum Lactate, and what is the difference between Type A and Type B Lactic Acidosis? | Normal venous/arterial Lactate: 0.5–2.0 mmol/L; Hyperlactatemia > 2.0 mmol/L indicates cellular stress (remeasure within 2–4 hours per Surviving Sepsis Campaign bundle), and Lactate >= 4.0 mmol/L indicates severe tissue hypoperfusion / septic shock requiring immediate 30 mL/kg IV balanced crystalloid resuscitation; Type A Lactic Acidosis is caused by tissue hypoxia/hypoperfusion (septic, cardiogenic, or hemorrhagic shock, mesenteric ischemia, cardiac arrest, seizures); Type B Lactic Acidosis occurs WITHOUT tissue hypoxia (metformin accumulation, thiamine deficiency, malignancy, liver failure, linezolid/NRTIs, cyanide). |